B
Bpifrance Portfolio holdings
AUM
$2.09B
This Quarter Return
-2.16%
1 Year Return
-46.97%
3 Year Return
-14.84%
5 Year Return
-4.77%
10 Year Return
–
AUM
$349M
AUM Growth
+$349M
(-14%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-14.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
2
Top Buys
| 1 |
CLLS
Cellectis
CLLS
|
$7.88M |
Top Sells
| 1 |
TLND
Talend S.A. American Depositary Shares
TLND
|
$55.9M |
| 2 |
Tempest Therapeutics
TPST
|
$883K |
| 3 |
SQNS
Sequans Communications
SQNS
|
$426K |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$218K |
Sector Composition
| 1 | Energy | 45.29% |
| 2 | Materials | 36.91% |
| 3 | Communication Services | 9.5% |
| 4 | Technology | 5.78% |
| 5 | Healthcare | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
TechnipFMC
FTI
$15.1B
| $158M | 45.29% | 24,688,691 | – | – |
|
2
Constellium
CSTM
$2.02B
| $129M | 36.91% | 16,393,903 | – | – |
|
3
Criteo
CRTO
$1.3B
| $33.1M | 9.5% | 2,718,752 | – | – |
|
|
SQNS
4
Sequans Communications
SQNS
$129M
| $20.2M | 5.79% | 3,378,963 -71,296 | -2% | -$426K |
|
|
CLLS
5
Cellectis
CLLS
$258M
| $7.88M | 2.26% | +425,726 | New | +$7.88M |
|
|
6
Tempest Therapeutics
TPST
$44M
| $875K | 0.25% | 536,805 -541,865 | -50% | -$883K |
|
|
7
Crinetics Pharmaceuticals
CRNX
$2.92B
| – | – | -12,418 | Closed | -$218K |
|
|
TLND
8
DELISTED
Talend S.A. American Depositary Shares
TLND
| – | – | -1,612,895 | Closed | -$55.9M |
|